Adenosine: A potential mediator of immunosuppression in multiple organ failure

G. Haskó, Edwin A. Deitch, Csaba Szabó, Zoltán H. Németh, E. Vízi

Research output: Article

56 Citations (Scopus)

Abstract

Multiple organ failure following a variety of insults, including, trauma, shock and pancreatitis, is the cause of 50-80% of all deaths in surgical intensive care units. In most patients, infections secondary to a general immunosuppressive state serve to trigger the development of multiple organ failure. This immunosuppressive state may be a consequence of excessive release of adenosine into the extracellular space, as adenosine has multiple immunosuppressive effects. Activation of adenosine receptors on immune cells inhibits the production of proinflammatory cytokines such as tumor necrosis factor α and interleukin (IL)-12, and increases the production of the anti-inflammatory cytokine IL-10. In addition, adenosine receptor activation appears to suppress cellular immunity by decreasing T helper cell (Th)1 and increasing Th2 responses. A deeper understanding of the role of adenosine in multiple organ failure may facilitate the development of adenosine-based therapeutic strategies.

Original languageEnglish
Pages (from-to)440-444
Number of pages5
JournalCurrent Opinion in Pharmacology
Volume2
Issue number4
DOIs
Publication statusPublished - aug. 1 2002

Fingerprint

Multiple Organ Failure
Adenosine
Immunosuppression
Immunosuppressive Agents
Purinergic P1 Receptors
Cytokines
Th1 Cells
Extracellular Space
Critical Care
Interleukin-12
Coinfection
Cellular Immunity
Pancreatitis
Interleukin-10
Intensive Care Units
Shock
Anti-Inflammatory Agents
Tumor Necrosis Factor-alpha
Wounds and Injuries
Therapeutics

ASJC Scopus subject areas

  • Cellular and Molecular Neuroscience
  • Pharmacology

Cite this

Adenosine : A potential mediator of immunosuppression in multiple organ failure. / Haskó, G.; Deitch, Edwin A.; Szabó, Csaba; Németh, Zoltán H.; Vízi, E.

In: Current Opinion in Pharmacology, Vol. 2, No. 4, 01.08.2002, p. 440-444.

Research output: Article

Haskó, G. ; Deitch, Edwin A. ; Szabó, Csaba ; Németh, Zoltán H. ; Vízi, E. / Adenosine : A potential mediator of immunosuppression in multiple organ failure. In: Current Opinion in Pharmacology. 2002 ; Vol. 2, No. 4. pp. 440-444.
@article{89c57a3d49724d9e86f18540854fc65e,
title = "Adenosine: A potential mediator of immunosuppression in multiple organ failure",
abstract = "Multiple organ failure following a variety of insults, including, trauma, shock and pancreatitis, is the cause of 50-80{\%} of all deaths in surgical intensive care units. In most patients, infections secondary to a general immunosuppressive state serve to trigger the development of multiple organ failure. This immunosuppressive state may be a consequence of excessive release of adenosine into the extracellular space, as adenosine has multiple immunosuppressive effects. Activation of adenosine receptors on immune cells inhibits the production of proinflammatory cytokines such as tumor necrosis factor α and interleukin (IL)-12, and increases the production of the anti-inflammatory cytokine IL-10. In addition, adenosine receptor activation appears to suppress cellular immunity by decreasing T helper cell (Th)1 and increasing Th2 responses. A deeper understanding of the role of adenosine in multiple organ failure may facilitate the development of adenosine-based therapeutic strategies.",
author = "G. Hask{\'o} and Deitch, {Edwin A.} and Csaba Szab{\'o} and N{\'e}meth, {Zolt{\'a}n H.} and E. V{\'i}zi",
year = "2002",
month = "8",
day = "1",
doi = "10.1016/S1471-4892(02)00172-8",
language = "English",
volume = "2",
pages = "440--444",
journal = "Current Opinion in Pharmacology",
issn = "1471-4892",
publisher = "Elsevier BV",
number = "4",

}

TY - JOUR

T1 - Adenosine

T2 - A potential mediator of immunosuppression in multiple organ failure

AU - Haskó, G.

AU - Deitch, Edwin A.

AU - Szabó, Csaba

AU - Németh, Zoltán H.

AU - Vízi, E.

PY - 2002/8/1

Y1 - 2002/8/1

N2 - Multiple organ failure following a variety of insults, including, trauma, shock and pancreatitis, is the cause of 50-80% of all deaths in surgical intensive care units. In most patients, infections secondary to a general immunosuppressive state serve to trigger the development of multiple organ failure. This immunosuppressive state may be a consequence of excessive release of adenosine into the extracellular space, as adenosine has multiple immunosuppressive effects. Activation of adenosine receptors on immune cells inhibits the production of proinflammatory cytokines such as tumor necrosis factor α and interleukin (IL)-12, and increases the production of the anti-inflammatory cytokine IL-10. In addition, adenosine receptor activation appears to suppress cellular immunity by decreasing T helper cell (Th)1 and increasing Th2 responses. A deeper understanding of the role of adenosine in multiple organ failure may facilitate the development of adenosine-based therapeutic strategies.

AB - Multiple organ failure following a variety of insults, including, trauma, shock and pancreatitis, is the cause of 50-80% of all deaths in surgical intensive care units. In most patients, infections secondary to a general immunosuppressive state serve to trigger the development of multiple organ failure. This immunosuppressive state may be a consequence of excessive release of adenosine into the extracellular space, as adenosine has multiple immunosuppressive effects. Activation of adenosine receptors on immune cells inhibits the production of proinflammatory cytokines such as tumor necrosis factor α and interleukin (IL)-12, and increases the production of the anti-inflammatory cytokine IL-10. In addition, adenosine receptor activation appears to suppress cellular immunity by decreasing T helper cell (Th)1 and increasing Th2 responses. A deeper understanding of the role of adenosine in multiple organ failure may facilitate the development of adenosine-based therapeutic strategies.

UR - http://www.scopus.com/inward/record.url?scp=0036667395&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036667395&partnerID=8YFLogxK

U2 - 10.1016/S1471-4892(02)00172-8

DO - 10.1016/S1471-4892(02)00172-8

M3 - Article

C2 - 12127878

AN - SCOPUS:0036667395

VL - 2

SP - 440

EP - 444

JO - Current Opinion in Pharmacology

JF - Current Opinion in Pharmacology

SN - 1471-4892

IS - 4

ER -